Silence Therapeutics Plc (SLNCF)
3.85
-0.15
(-3.75%)
USD |
OTCM |
Oct 09, 16:00
Silence Therapeutics Free Cash Flow (Quarterly) : 1.548M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.548M |
| March 31, 2026 | -15.60M |
| December 31, 2025 | -16.66M |
| September 30, 2025 | -11.08M |
| June 30, 2025 | -22.84M |
| March 31, 2025 | -12.31M |
| September 30, 2024 | -25.02M |
| June 30, 2024 | -5.382M |
| March 31, 2024 | -9.143M |
| Date | Value |
|---|---|
| December 31, 2023 | -14.25M |
| September 30, 2023 | -5.500M |
| June 30, 2023 | -18.88M |
| March 31, 2023 | -9.147M |
| December 31, 2022 | -16.07M |
| September 30, 2022 | -11.10M |
| June 30, 2022 | -10.41M |
| March 31, 2022 | -19.35M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -2.616M |
| Mereo BioPharma Group Plc | -6.049M |
| Compass Pathways Plc | -40.37M |
| HemoGenyx Pharmaceuticals Plc | -- |